AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 90 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $134,000 | +106.2% | 3,876 | 0.0% | 0.01% | +100.0% |
| Q2 2020 | $65,000 | +16.1% | 3,876 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $56,000 | -56.9% | 3,876 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $130,000 | +71.1% | 3,876 | +7.4% | 0.01% | +100.0% |
| Q3 2019 | $76,000 | +1.3% | 3,609 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $75,000 | -7.4% | 3,609 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $81,000 | -5.8% | 3,609 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $86,000 | -12.2% | 3,609 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $98,000 | +1.0% | 3,609 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $97,000 | -1.0% | 3,609 | +16.8% | 0.01% | 0.0% |
| Q1 2018 | $98,000 | -16.2% | 3,089 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $117,000 | +77.3% | 3,089 | 0.0% | 0.01% | +66.7% |
| Q3 2017 | $66,000 | +3.1% | 3,089 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $64,000 | +42.2% | 3,089 | +50.8% | 0.00% | +50.0% |
| Q1 2017 | $45,000 | – | 2,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|